Invitation to presentation of Recipharm’s interim report for the first quarter 2016 on the 28th April

Recipharm will publish its interim report for January-March 2016 on 28 April at
07:45 am CET.
The company invites investors, analysts and media to a web conference (in
English) on 28 April at 10:00 am CET, where CEO Thomas Eldered and CFO Björn
Westberg will present and comment on the report as well as answer questions.

The report will be available on Recipharm’s website www.recipharm.com/investor
-relations from 07:45 am CET the same day and the presentation from the webcast
will be uploaded during the day on the 28 April.
To participate in the web conference, please use the below link:
http://edge.media-server.com/m/p/a7pkzj8w
Questions may be submitted by dialing below telephone numbers or by typing them
in the Q&A box during the conference. If you don’t wish to ask questions by
telephone you only need to participate through the link above.

From Sweden: + 46 8 505 963 06
From Denmark: + 45 354 45597
From Finland: + 358 9 8171 0317
From France: + 33 29092 0977
From Germany: + 49 30 211 510 067
From India: + 91 226187 51 03
From Italy: + 39 2 3604 67 98
From Norway: + 47 235 00 559
From Portugal: + 35 210 609104
From Spain: + 34 911 143 608
From Switzerland: + 41 44 5800083
From the UK: + 44 203 139 48 30
From the USA: + 1 718 873 90 77

Pin code for participants:
38308984#
For more information, please contact:
Björn Westberg, CFO, +46 8 602 46 20, ir@recipharm.com

For questions about participation in the event, please contact:
Linda Holmström, Brand & Communications Manager, + 46 8 602 45 13,
linda.holmstrom@recipharm.com
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52
00, Fax 46 8 81 87 03
www.recipharm.com